Murphy Erin S, Sahgal Arjun, Regis Jean, Levivier Marc, Fariselli Laura, Gorgulho Alessandra, Ma Lijun, Pollock Bruce, Yomo Shoji, Sheehan Jason, Paddick Ian, Suh John H, Saxena Anshul, Ahmed Md Ashfaq, Kotecha Rupesh
Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio, USA.
Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, Toronto, Canada.
Neuro Oncol. 2025 Feb 10;27(2):517-532. doi: 10.1093/neuonc/noae204.
There are limited data on the use of stereotactic radiosurgery (SRS) for pediatric patients. The aim of this systematic review was to summarize indications and outcomes specific to pediatric cranial SRS to inform consensus guidelines on behalf of the International Stereotactic Radiosurgery Society.
A systematic review, using the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-analyses, analyzed English-language articles on SRS, published between 1989 and 2021, that included outcomes for at least 5 pediatric patients. MEDLINE database terms included tumor types and locations, and radiosurgical and age-specific terms. We excluded nonclinical reports, expert opinions, commentaries, and review articles. Meta-regressions for associations with local control were performed for medulloblastoma, craniopharyngioma, ependymoma, glioma, and arteriovenous malformation (AVM).
Of the 113 articles identified for review, 68 met the inclusion criteria. These articles described approximately 400 pediatric patients with benign and malignant brain tumors and 5119 with AVMs who underwent cranial SRS. The rates of local control for benign tumors, malignant tumors, and AVMs were 89% (95% CI, 82%-95%), 71% (95% CI, 59%-82%), and 65% (95% CI, 60%-69%), respectively. No significant associations were identified for local control with the patient-, tumor-, or treatment-related variables.
This review is the first to summarize outcomes specific to SRS for pediatric brain tumors and AVMs. Although data reporting is limited for pediatric patients, SRS appears to provide acceptable rates of local control. We present ISRS consensus guidelines to inform the judicious use of cranial SRS for pediatric patients.
关于立体定向放射外科(SRS)在儿科患者中的应用数据有限。本系统评价的目的是总结儿科颅部SRS的特定适应证和治疗结果,以便代表国际立体定向放射外科学会制定共识指南。
采用系统评价和Meta分析的首选报告项目指南进行系统评价,分析1989年至2021年间发表的关于SRS的英文文章,这些文章至少纳入了5例儿科患者的治疗结果。MEDLINE数据库检索词包括肿瘤类型和位置以及放射外科和特定年龄的术语。我们排除了非临床报告、专家意见、评论和综述文章。对髓母细胞瘤、颅咽管瘤、室管膜瘤、胶质瘤和动静脉畸形(AVM)进行了与局部控制相关的Meta回归分析。
在113篇被确定用于综述的文章中,68篇符合纳入标准。这些文章描述了约400例患有良性和恶性脑肿瘤的儿科患者以及5119例接受颅部SRS治疗的AVM患者。良性肿瘤、恶性肿瘤和AVM的局部控制率分别为89%(95%CI,82%-95%)、71%(95%CI,59%-82%)和65%(95%CI,60%-69%)。未发现局部控制与患者、肿瘤或治疗相关变量之间存在显著关联。
本综述首次总结了SRS治疗儿科脑肿瘤和AVM的特定结果。尽管儿科患者的数据报告有限,但SRS似乎能提供可接受的局部控制率。我们提出了国际立体定向放射外科学会的共识指南,以指导儿科患者颅部SRS的合理应用。